Editorial: Inhibitors of the platelet thrombin receptor: Will they live up to their promises?

Circulation

Volumn 123, Issue 17, 2011, Pages 1833-1835

  Van De Werf, Frans ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Editorials; inhibitors; platelets; receptors

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; APIXABAN; ATOPAXAR; BETRIXABAN; CLOPIDOGREL; DABIGATRAN; DIPYRIDAMOLE; EDOXABAN; ELINOGREL; ENOXAPARIN; EPTIFIBATIDE; FONDAPARINUX; HIRULOG; PRASUGREL; RIVAROXABAN; TAK 442; THROMBIN RECEPTOR ANTAGONIST; TICAGRELOR; TICLOPIDINE; TIROFIBAN; UNCLASSIFIED DRUG; VORAPAXAR; YM 150; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; THROMBIN RECEPTOR;

ANTICOAGULANT THERAPY; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BLEEDING; BLEEDING TENDENCY; BLOOD CLOTTING PARAMETERS; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; DOSE RESPONSE; DRUG POTENCY; EDITORIAL; HUMAN; LIVER DYSFUNCTION; LOADING DRUG DOSE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; QT PROLONGATION; DRUG ANTAGONISM; DRUG EFFECT; NOTE; THROMBOCYTE; THROMBOSIS;

BLOOD PLATELETS; FIBRINOLYTIC AGENTS; HUMANS; PLATELET AGGREGATION INHIBITORS; RECEPTORS, THROMBIN; THROMBOSIS;

EID: 79955618078     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.021733     Document Type: Editorial

References (8)

1. O'Donoghue ML, Bhatt DL, Wiviott SD, Goodman SG, Fitzgerald DJ, Angiolillo DJ, Goto S, Montalescot M, Zeymer U, Aylward PE, Guetta V, Dudek D, Ziecina R, Contant CF, Flather MD; on behalf of the LANCELOT-ACS Investigators. Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the Lessons From Antagonizing the Cellular Effects of Thrombin-Acute Coronary Syndromes trial. Circulation. 2011;123:1843-1853.
2. Wiviott SD, Flather MD, O'Donoghue ML, Goto S, Fitzgerald DJ, Cura F, Aylward P, Guetta V, Dudek D, Contant CF, Angiolillo DJ, Bhatt DL; on behalf of the LANCELOT-CAD Investigators. Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the Lessons From Antagonizing the Cellular Effect of Thrombin-Coronary Artery Disease trial. Circulation. 2011;123:1854 -1863.
3. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
4. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ; MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364: 331-337.
5. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM, for the TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001-2015. (Pubitemid 350106708)
6. Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, Vandermaelen C, Voigt T, Weber M, Yoon BW, for the PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008;359:1238-1251.
7. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, for the PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045-1057.
8. Fox KAA, Carruthers KF, Dunbar DR, Graham C, Manning JR, De Raedt H, Buysschaert I, Lambrechts D, Van de Werf F. Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study). Eur Heart J. 2010;31:2755-2764.